Stoke Therapeutics Inc

NASDAQ:STOK   3:59:56 PM EDT
14.14
+0.49 (+3.59%)
Earnings Announcements

Stoke Therapeutics Reports First Quarter Financial Results And Provides Business Updates

Published: 05/10/2022 11:38 GMT
Stoke Therapeutics Inc (STOK) - Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates.
Revenue is expected to be $2.27 Million
Adjusted EPS is expected to be -$0.70

Next Quarter Revenue Guidance is expected to be $2.8 Million
Next Quarter EPS Guidance is expected to be -$0.72

More details on our Analysts Page.